A Look at the Financial Performance, Company Strategy and Future Forecasts Of UCB.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles. -- Research and Markets (http://www.researchandmarkets.com/reports/c31460) has announced the addition of UCB UCB - University of California at Berkeley : Pharmavitae Profile 2005 to their offering. Introduction This analysis examines the current position and future outlook for UCB in the ethical pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts Sales forecast A key input to a firm's financial planning process. External sales forecasts are based on historical experience, statistical analysis, and consideration of various macroeconomic factors. for key drugs. An interactive forecasting and analysis tool provides continually con·tin·u·al adj. 1. Recurring regularly or frequently: the continual need to pay the mortgage. 2. updated quantitative and qualitative information. Reasons to Purchase --Understand the competitive forces facing UCB, and why the company has a promising revenue outlook with a forecast 2004-10 sales CAGR CAGR See: Compound Annual Growth Rate of 13.5%. --Learn how Celltech's AIID AIID Autoimmune and Inflammatory Disorders AIID Association des Infirmiers(ères) Intervenant(e)s en Diabétologie antibody Cimzia will become the primary growth driver for UCB over the 2007-10 period. Topics Covered CHAPTER 1 Key findings Strategic outlook Strategic recommendations Current positioning: competitive outlook 2004 UCB's forecast revenue stream, 2005-10 Key issues facing UCB: 2005-10 Key issues facing UCB: 2005-10 CHAPTER 2 GLOBAL COMPANY STRATEGY Introduction to UCB Assessment of strategic position Strengths Weaknesses Opportunities Threats Strategic recommendations Therapeutic foci Evolution of R&D focus Growth strategy assessment Organic growth Partnerships/licensing Mergers and acquisitions CHAPTER 3 GLOBAL PORTFOLIO AND PIPELINE ANALYSIS 37. Therapy area focus in 2004 Evolution of therapy area focus, 2004-10 Key growth drivers and resistors of future performance, 2005-10 UCB's Respiratory franchise Marketed products R&D compounds Respiratory portfolio sales forecasts and forecast revenue growth UCB's CNS See Continuous net settlement. CNS See continuous net settlement (CNS). franchise Marketed products R&D compounds CNS portfolio sales forecasts and forecast revenue growth UCB's Other products Marketed products R&D compounds Other products sales forecasts and forecast revenue growth CHAPTER 4 US STRATEGY, PORTFOLIO AND PIPELINE US Company Strategy Introduction to UCB's presence in the US US marketing strategy US product sourcing strategy US Portfolio and pipeline analysis US evolution of therapy area focus, 2004-10 86US business development by therapy area UCB's Respiratory portfolio US sales forecasts and forecast revenue growth 91 UCB's CNS portfolio US sales forecasts and forecast revenue growth 92 UCB's Other portfolio US sales forecasts and forecast revenue growth 93 CHAPTER 5 CORPORATE DEVELOPMENT Financial position, 2003-04 Financial position, 2003-04 Revenue growth Historical assessment of UCB's profitability, 2000-04 Cost structure 2004 operating cost ratio benchmarking Business model clustering according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. 2004 cost ratios Liquidity, 2000-04 2004 growth and investment momentum CHAPTER 6 APPENDIX : SUPPORTING DATA 103. Exchange rates LIST OF TABLES LIST OF FIGURES For more information visit http://www.researchandmarkets.com/reports/c31460 Source: Datamonitor Datamonitor is a provider of online database and analysis services. The company is based in the United Kingdom and also has offices in the United States, Japan, and other countries.[1] The Datamonitor team includes analysts and professional researchers. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion